5-[(1-{[(4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy]carbonyl}-4-piperidinyl)amino]pentanoic acid(CAS: 181467-56-1)

This compound exhibits a crystalline form with a molecular weight of approximately 675.7 g/mol. It has a low solubility in water but is soluble in organic solvents like methanol and acetonitrile. The compound is reactive towards nucleophiles and can undergo esterification and amide formation. It is stable under neutral and slightly acidic conditions but may hydrolyze under strongly acidic or basic conditions.

The compound is synthesized via a multi-step process involving the condensation of a piperidine derivative with an indolizinoquinoline derivative. The reaction is catalyzed by a suitable acid acceptor and proceeds through a Michael addition followed by saponification. The overall yield is moderate, around 50-60%, and the reaction is highly selective.

This compound is primarily used in the pharmaceutical industry for its potential as a bioactive molecule. It may also find applications in the sensor industry due to its specific optical and electronic properties, although detailed uses in this field are limited.

Proper personal protective equipment (PPE) is essential, including gloves, goggles, and a lab coat. This compound should be handled in a well-ventilated area or a fume hood. Spills should be cleaned up using appropriate absorbent materials and disposal should follow local regulations. A Safety Data Sheet (SDS) should be consulted for detailed handling and storage information.